Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Cognitive Effects of Interferon in Patients With Melanoma
- Status
- COMPLETED
- Phase
- N/A
Ensuring Communication in Hospice by Oncology Study (ECHO)
- Status
- COMPLETED
- Phase
- NA
A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Biomarker Correlates of Hypoxia in Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
- Status
- COMPLETED
- Phase
- N/A
Infrared Lymphangiography as a Method of Sentinel Node Identification
- Status
- COMPLETED
- Phase
- NA
Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ipilimumab 12-month Intensive Pharmacovigilance Protocol
- Status
- COMPLETED
- Phase
- N/A
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
- Status
- COMPLETED
- Phase
- PHASE1
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
- Status
- COMPLETED
- Phase
- NA
Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
IVAC MUTANOME Phase I Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE1
Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1